Skip to main content

Table 2 Reported cytogenetic translocations involving Xp11.2/transcription factor E3 (TFE3)

From: Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature

Chromosome Translocation

Gene Fusion

Neoplasm

Source, Year

der(17)t(X;17)(p11.2;q25)

ASPL-TFE3

ASPS

Argani et al, 2001 [1];

Argani et al, 2007 [17]

t(X;17)(p11.2;q25)

ASPL-TFE3

RCC

Argani et al, 2001 [1];

Argani et al, 2007 [17]

t(X;1)(p11.2;q21)

PRCC-TFE3

RCC

Argani et al, 2007 [17]

t(X;1)(p11.2;p34)

PSF-TFE3

RCC

Argani et al, 2007 [17]

inv(X)(p11.2;q12)

NONO-TFE3

RCC

Argani et al, 2007 [17]

t(X;17)(p11.2;q23)

CLTC-TFE3

RCC

Argani et al, 2003 [8];

Argani et al, 2007 [17]

t(X;3)(p11.2;q23)

Unknown

RCC

Argani et al, 2007 [17]

  1. ASPL, alveolar soft part sarcoma locus; ASPS, alveolar soft part sarcoma; CLTC, clathrin heavy chain; NONO, non-POU domain-containing octamer-binding; PRCC, papillary renal cell carcinoma; PSF, polypyrimidine tract binding protein-associated splicing factor; RCC, renal cell carcinoma